7.11.2014 - Notice within the graduated plan procedure ("Stufenplanverfahren")

In its notice of 5 November 2014, the Federal Institute for Drugs and Medical Devices (BfArM) has ruled the realisation of the corresponding implementing decision C(2014)7147of the EU Commission.

24.07.2014 - CHMP opinion

The European Medicines Agency has concluded its review of emergency contraceptives containing levonorgestrel or ulipristal acetate.

For further information click on the following link:

Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight

24.01.2014 - Procedure started

The BfArM issues information on the initiation of a European review in accordance with Article 31 of Directive 2001/83/EC

Further information

For details on the procedure please click on the following link to the homepage of the European Medicines Agency (EMA):

Emergency contraceptives

To the risk assessment procedure (available in German only)